{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:03:33Z","timestamp":1790737413787,"version":"4.1.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100032910","name":"Datta Meghe Institute of Higher Education and Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100032910","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discover Nano"],"DOI":"10.1186\/s11671-026-04727-y","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:40:17Z","timestamp":1781332817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nanotechnology based topical drug delivery systems for psoriasis addressing current strategies clinical progress and manufacturing challenges"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6682-3161","authenticated-orcid":false,"given":"Shritesh","family":"Bhoyar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-1847","authenticated-orcid":false,"given":"Anil","family":"Pethe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"4727_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.941071","volume":"13","author":"M Kamata","year":"2022","unstructured":"Kamata M, Tada Y. Dendritic cells and macrophages in the pathogenesis of psoriasis. Front Immunol. 2022;13:941071. https:\/\/doi.org\/10.3389\/fimmu.2022.941071.","journal-title":"Front Immunol"},{"issue":"3","key":"4727_CR2","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","volume":"21","author":"A Raharja","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med. 2021;21(3):170\u20133. https:\/\/doi.org\/10.7861\/clinmed.2021-0257.","journal-title":"Clin Med"},{"issue":"19","key":"4727_CR3","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.3390\/healthcare13192437","volume":"13","author":"D Li","year":"2025","unstructured":"Li D, Fan S, Song J, Zhao H, Guo L, Li P, et al. Global psoriasis burden 1990\u20132021: evolving patterns and socio-demographic correlates in the global burden of disease 2021 update. Healthcare. 2025;13(19):2437. https:\/\/doi.org\/10.3390\/healthcare13192437.","journal-title":"Healthcare"},{"key":"4727_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2025.08.038","author":"J Wei","year":"2025","unstructured":"Wei J, Wang Y, Chen Y, Wang Z, Dai X, Gelfand JM, et al. Global burden of psoriasis from 1990 to 2021 and potential factors: a systematic analysis. J Investig Dermatol. 2025. https:\/\/doi.org\/10.1016\/j.jid.2025.08.038.","journal-title":"J Investig Dermatol"},{"key":"4727_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2025.1518681","author":"J Xiong","year":"2025","unstructured":"Xiong J, Xue T, Tong M, Xu L, Bai B. Dynamic trend analysis of global psoriasis burden from 1990 to 2021: a study of gender, age, and regional differences based on GBD 2021 data. Front Public Health. 2025. https:\/\/doi.org\/10.3389\/fpubh.2025.1518681.","journal-title":"Front Public Health"},{"key":"4727_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.115429","volume":"165","author":"MBS Gon\u00e7alves","year":"2025","unstructured":"Gon\u00e7alves MBS, Fonseca M, Mascarenhas-Melo F, Figueiras A. Advancing insights into psoriasis: from pathogenesis to current and emerging therapies. Int Immunopharmacol. 2025;165:115429. https:\/\/doi.org\/10.1016\/j.intimp.2025.115429.","journal-title":"Int Immunopharmacol"},{"issue":"7564","key":"4727_CR7","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1136\/bmj.333.7564.380","volume":"333","author":"CH Smith","year":"2006","unstructured":"Smith CH, Barker JNWN. Psoriasis and its management. BMJ. 2006;333(7564):380\u20134. https:\/\/doi.org\/10.1136\/bmj.333.7564.380.","journal-title":"BMJ"},{"key":"4727_CR8","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.2147\/IJN.S529899","volume":"20","author":"Y Liu","year":"2025","unstructured":"Liu Y, Chang R, Deng H, Liang F, Xu X, Luo Y. Advances in the drug delivery systems for psoriasis topical therapy. Int J Nanomed. 2025;20:12307\u201329. https:\/\/doi.org\/10.2147\/IJN.S529899.","journal-title":"Int J Nanomed"},{"issue":"11","key":"4727_CR9","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1016\/j.apsb.2024.08.027","volume":"14","author":"B Xie","year":"2024","unstructured":"Xie B, Liu Y, Li X, Yang P, He W. Solubilization techniques used for poorly water-soluble drugs. Acta Pharm Sin B. 2024;14(11):4683\u2013716. https:\/\/doi.org\/10.1016\/j.apsb.2024.08.027.","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"4727_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/1574886315666200128095958","volume":"15","author":"H Bakshi","year":"2020","unstructured":"Bakshi H, Nagpal M, Singh M, Dhingra GA, Aggarwal G. Treatment of psoriasis: a comprehensive review of entire therapies. Curr Drug Saf. 2020;15(2):82\u2013104. https:\/\/doi.org\/10.2174\/1574886315666200128095958.","journal-title":"Curr Drug Saf"},{"issue":"2","key":"4727_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s40257-023-00837-w","volume":"25","author":"RW Kim","year":"2024","unstructured":"Kim RW, Lam M, Abuabara K, Simpson EL, Drucker AM. Targeted systemic therapies for adults with atopic dermatitis: selecting from biologics and JAK inhibitors. Am J Clin Dermatol. 2024;25(2):179\u201393. https:\/\/doi.org\/10.1007\/s40257-023-00837-w.","journal-title":"Am J Clin Dermatol"},{"key":"4727_CR12","doi-asserted-by":"publisher","DOI":"10.1063\/5.0204909","author":"S Priya","year":"2024","unstructured":"Priya S, Desai VM, Singhvi G. Tailoring lyotropic liquid crystals for skin barrier penetration: Exploring composition and structure\u2013function relationships. Appl Phys Rev. 2024. https:\/\/doi.org\/10.1063\/5.0204909.","journal-title":"Appl Phys Rev"},{"key":"4727_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2025.214625","volume":"180","author":"AVP Silvestrini","year":"2026","unstructured":"Silvestrini AVP, da Silva UJ, Morais MF, Depieri LV, Bentley MVLB. Integrating clinical challenges and nanotechnological based approaches for psoriasis therapy. Biomater Adv. 2026;180:214625. https:\/\/doi.org\/10.1016\/j.bioadv.2025.214625.","journal-title":"Biomater Adv"},{"issue":"9","key":"4727_CR14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/jpp\/rgac006","volume":"74","author":"CO Alves","year":"2022","unstructured":"Alves CO, Novaes RD, Bernardes MTCP, Gon\u00e7alves RV, da Silva LP, Agostini SBN, et al. Evaluation of methotrexate-loaded surfactants, ceramides and cholesterol-based lamellar phases as a topical treatment for psoriasis. J Pharm Pharmacol. 2022;74(9):1342\u201352. https:\/\/doi.org\/10.1093\/jpp\/rgac006.","journal-title":"J Pharm Pharmacol"},{"key":"4727_CR15","doi-asserted-by":"publisher","DOI":"10.2174\/0124681873413875251111055219","author":"K Saini","year":"2025","unstructured":"Saini K, Parashar AK, Sethi VA. Nanotechnology in psoriasis management: a new frontier in drug delivery. Curr Nanomed. 2025. https:\/\/doi.org\/10.2174\/0124681873413875251111055219.","journal-title":"Curr Nanomed"},{"key":"4727_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106612","volume":"191","author":"S Hatem","year":"2023","unstructured":"Hatem S, El-Kayal M. Novel anti-psoriatic nanostructured lipid carriers for the cutaneous delivery of luteolin: a comprehensive in-vitro and in-vivo evaluation. Eur J Pharm Sci. 2023;191:106612. https:\/\/doi.org\/10.1016\/j.ejps.2023.106612.","journal-title":"Eur J Pharm Sci"},{"issue":"3","key":"4727_CR17","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.3390\/ijms24032978","volume":"24","author":"TS Patil","year":"2023","unstructured":"Patil TS, Gujarathi NA, Aher AA, Pachpande HE, Sharma C, Ojha S, et al. Recent advancements in topical anti-psoriatic nanostructured lipid carrier-based drug delivery. Int J Mol Sci. 2023;24(3):2978. https:\/\/doi.org\/10.3390\/ijms24032978.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4727_CR18","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s00403-024-02846-z","volume":"316","author":"K Wang","year":"2024","unstructured":"Wang K, Zhao Y, Cao X. Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030. Arch Dermatol Res. 2024;316(4):114. https:\/\/doi.org\/10.1007\/s00403-024-02846-z.","journal-title":"Arch Dermatol Res"},{"key":"4727_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1590","author":"R Parisi","year":"2020","unstructured":"Parisi R, Iskandar IYK, Kontopantelis E, Augustin M, Griffiths CEM, Ashcroft DM. National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study. BMJ. 2020. https:\/\/doi.org\/10.1136\/bmj.m1590.","journal-title":"BMJ"},{"key":"4727_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2308682","author":"M-L Schaarschmidt","year":"2024","unstructured":"Schaarschmidt M-L, Kromer D, Wellmann P, Peitsch WK, Kromer C. Patients\u2019 preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most. J Dermatol Treat. 2024. https:\/\/doi.org\/10.1080\/09546634.2024.2308682.","journal-title":"J Dermatol Treat"},{"issue":"2","key":"4727_CR21","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jid.2018.07.029","volume":"139","author":"A Egeberg","year":"2019","unstructured":"Egeberg A, Thyssen JP, Burisch J, Colombel J-F. Incidence and risk of inflammatory bowel disease in patients with psoriasis\u2014a nationwide 20-year cohort study. J Investig Dermatol. 2019;139(2):316\u201323. https:\/\/doi.org\/10.1016\/j.jid.2018.07.029.","journal-title":"J Investig Dermatol"},{"key":"4727_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102614","volume":"118","author":"AK Srivastava","year":"2021","unstructured":"Srivastava AK, Chand Yadav T, Khera HK, Mishra P, Raghuwanshi N, Pruthi V, et al. Insights into interplay of immunopathophysiological events and molecular mechanistic cascades in psoriasis and its associated comorbidities. J Autoimmun. 2021;118:102614. https:\/\/doi.org\/10.1016\/j.jaut.2021.102614.","journal-title":"J Autoimmun"},{"issue":"10","key":"4727_CR23","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1007\/s13555-023-01014-x","volume":"13","author":"G Girolomoni","year":"2023","unstructured":"Girolomoni G, Savage L, Gisondi P, Svensson \u00c5, Mah\u00e9 E, Augustin M, et al. Increasing access to effective systemic treatments in patients with moderate-to-severe psoriasis: narrative review. Dermatol Ther (Heidelb). 2023;13(10):2171\u201385. https:\/\/doi.org\/10.1007\/s13555-023-01014-x.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"4727_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3461765","author":"S Liu","year":"2022","unstructured":"Liu S, Yan Z, Liu Q. [Retracted] The burden of psoriasis in China and Global Level from 1990 to 2019: a systematic analysis from the global burden of disease study 2019. Biomed Res Int. 2022. https:\/\/doi.org\/10.1155\/2022\/3461765.","journal-title":"Biomed Res Int"},{"issue":"5","key":"4727_CR25","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/ijd.14864","volume":"59","author":"S AlQassimi","year":"2020","unstructured":"AlQassimi S, AlBrashdi S, Galadari H, Hashim MJ. Global burden of psoriasis: comparison of regional and global epidemiology, 1990 to 2017. Int J Dermatol. 2020;59(5):566\u201371. https:\/\/doi.org\/10.1111\/ijd.14864.","journal-title":"Int J Dermatol"},{"issue":"6","key":"4727_CR26","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1021\/acs.biomac.8b00127","volume":"19","author":"U Capasso Palmiero","year":"2018","unstructured":"Capasso Palmiero U, Huo M, Zhang Y, Zeng M, Liu L, Wei Y, et al. Zwitterionic polyester-based nanoparticles with tunable size and degradation for drug delivery. Biomacromol. 2018;19(6):2267\u201377. https:\/\/doi.org\/10.1021\/acs.biomac.8b00127.","journal-title":"Biomacromol"},{"issue":"11","key":"4727_CR27","doi-asserted-by":"publisher","first-page":"16706","DOI":"10.1021\/acsanm.2c03712","volume":"5","author":"CJ Perecin","year":"2022","unstructured":"Perecin CJ, Palmiero UC, Huo M, Zhang Y, Zeng M, Liu L, et al. Magnetite nanoparticles coated with biodegradable zwitterionic polymers as multifunctional nanocomposites for drug delivery and cancer treatment. ACS Appl Nano Mater. 2022;5(11):16706\u201319. https:\/\/doi.org\/10.1021\/acsanm.2c03712","journal-title":"ACS Appl Nano Mater"},{"issue":"37","key":"4727_CR28","doi-asserted-by":"publisher","first-page":"48969","DOI":"10.1021\/acsami.4c06720","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen Y, Liang C-L, Liu H, Chen H, He Y, Lin J, et al. Percutaneous delivery of hederacoside C-loaded nanoliposome gel alleviates psoriasiform skin inflammation through the CCL17\/Treg axis. ACS Appl Mater Interfaces. 2024;16(37):48969\u201381. https:\/\/doi.org\/10.1021\/acsami.4c06720.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"35","key":"4727_CR29","doi-asserted-by":"publisher","first-page":"46123","DOI":"10.1021\/acsami.4c10067","volume":"16","author":"T Wu","year":"2024","unstructured":"Wu T, Zhang J, Jing X, Wang Z, Wu Z, Zhang H, et al. Multiple RONS-loaded plasma-activated ice microneedle patches for transdermal treatment of psoriasis. ACS Appl Mater Interfaces. 2024;16(35):46123\u201332. https:\/\/doi.org\/10.1021\/acsami.4c10067.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"8","key":"4727_CR30","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.3390\/ijms23084237","volume":"23","author":"D Kocsis","year":"2022","unstructured":"Kocsis D, Horv\u00e1th S, Kem\u00e9ny \u00c1, Varga-Medveczky Z, Pongor C, Moln\u00e1r R, et al. Drug delivery through the psoriatic epidermal barrier\u2014a \u201cskin-on-a-chip\u201d permeability study and ex vivo optical imaging. Int J Mol Sci. 2022;23(8):4237. https:\/\/doi.org\/10.3390\/ijms23084237.","journal-title":"Int J Mol Sci"},{"key":"4727_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.matlet.2024.136436","volume":"365","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zhu X, Zhang Z, Qin J, Kong F. All-trans retinoic acid-hyaluronic acid prodrug nanoparticles for enhanced in vivo anti-psoriatic effect. Mater Lett. 2024;365:136436. https:\/\/doi.org\/10.1016\/j.matlet.2024.136436.","journal-title":"Mater Lett"},{"key":"4727_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtcomm.2022.104409","volume":"33","author":"M Ghorbanzadeh","year":"2022","unstructured":"Ghorbanzadeh M, Golmohammadzadeh S, Karimi M, Farhadian N. Evaluation of vitamin D3 serum level of microemulsion based hydrogel containing Calcipotriol drug. Mater Today Commun. 2022;33:104409. https:\/\/doi.org\/10.1016\/j.mtcomm.2022.104409.","journal-title":"Mater Today Commun"},{"issue":"4","key":"4727_CR33","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3390\/gels11040228","volume":"11","author":"R Jia","year":"2025","unstructured":"Jia R, Liu Y, Wu Y, Shen S, Cao K, Chen X, et al. Liposomes-in-gel as the docetaxel delivery for the effective treatment of psoriasis by inhibiting the proliferation of blood vessels. Gels. 2025;11(4):228. https:\/\/doi.org\/10.3390\/gels11040228.","journal-title":"Gels"},{"key":"4727_CR34","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1186\/s12951-024-02860-3","volume":"22","author":"P Wang","year":"2024","unstructured":"Wang P, Hong S, Cao C, Guo S, Wang C, Chen X, et al. Ethosomes-mediated tryptanthrin delivery as efficient anti-psoriatic nanotherapy by enhancing topical drug absorption and lipid homeostasis. J Nanobiotechnol. 2024;22:584. https:\/\/doi.org\/10.1186\/s12951-024-02860-3.","journal-title":"J Nanobiotechnol"},{"issue":"10","key":"4727_CR35","first-page":"242","volume":"14","author":"U Singh","year":"2023","unstructured":"Singh U, Hak J, Sharma UK, Vishvakarma P. Formulation and evaluation of niosome gel on psoriasis. J Cardiovasc Dis Res. 2023;14(10):242\u201353.","journal-title":"J Cardiovasc Dis Res"},{"key":"4727_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115823","volume":"168","author":"P Rahmanian-Devin","year":"2023","unstructured":"Rahmanian-Devin P, Askari VR, Sanei-Far Z, Baradaran Rahimi V, Kamali H, Jaafari MR, et al. Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesions. Biomed Pharmacother. 2023;168:115823. https:\/\/doi.org\/10.1016\/j.biopha.2023.115823.","journal-title":"Biomed Pharmacother"},{"key":"4727_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202503282","volume":"15","author":"R Jebbawi","year":"2026","unstructured":"Jebbawi R, Oukhrib A, Clement E, Labie H, Cassel S, Fruchon S, et al. Increased anti-psoriatic effect of anti-inflammatory dendrimers using fluid catanionic vesicle-based topical formulations. Adv Healthc Mater. 2026;15:e03282. https:\/\/doi.org\/10.1002\/adhm.202503282.","journal-title":"Adv Healthc Mater"},{"key":"4727_CR38","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/gels10110675","volume":"10","author":"B Balogh","year":"2024","unstructured":"Balogh B, Peto A, Haimhoffer A, Sinka D, Kosa D, Feher P, et al. Formulation and evaluation of different nanogels of tapinarof for treatment of psoriasis. Gels. 2024;10:675. https:\/\/doi.org\/10.3390\/gels10110675.","journal-title":"Gels"},{"key":"4727_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105967","volume":"99","author":"GS Gomes","year":"2024","unstructured":"Gomes GS, Benin T, Ferreira ECJ, Palma VM, Alves ACS, Visioli F, et al. Pectin-based hydrogel loaded with polymeric nanocapsules for the cutaneous delivery of tacrolimus: A targeted approach for the treatment of psoriasis. J Drug Deliv Sci Technol. 2024;99:105967. https:\/\/doi.org\/10.1016\/j.jddst.2024.105967.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4727_CR40","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.2147\/IJN.S461514","volume":"19","author":"P An","year":"2024","unstructured":"An P, Zhao Q, Hao S, Wang X, Tian J, Ma Z. Recent advancements and trends of topical drug delivery systems in psoriasis: a review and bibliometric analysis. Int J Nanomed. 2024;19:7631\u201371. https:\/\/doi.org\/10.2147\/IJN.S461514.","journal-title":"Int J Nanomed"},{"key":"4727_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2026.107429","volume":"218","author":"M Kaplan","year":"2026","unstructured":"Kaplan M, Arslan FB, Ozturk SC, Uluturk S, Aydin Mericoz C, Esendagli G, et al. Development and in vitro\/in vivo evaluation of polymeric dissolving microneedle formulation for psoriasis treatment. Eur J Pharm Sci. 2026;218:107429. https:\/\/doi.org\/10.1016\/j.ejps.2026.107429.","journal-title":"Eur J Pharm Sci"},{"key":"4727_CR42","doi-asserted-by":"publisher","DOI":"10.2174\/0122106812377833250702181018","author":"G Raj","year":"2025","unstructured":"Raj G, Halagali P, Prem S, Surya CS, Somanna P, Sharma H. Formulation and evaluation of a nanoemulsion gel for the improved topical delivery of dithranol in psoriasis. Nanosci Nanotechnol Asia. 2025. https:\/\/doi.org\/10.2174\/0122106812377833250702181018.","journal-title":"Nanosci Nanotechnol Asia"},{"key":"4727_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107291","volume":"112","author":"AM Kamel","year":"2025","unstructured":"Kamel AM, El-Kamel AH, Allam EA, Bakr BA, Ashour AA. Bioactive hydrogel-based nanosponges for enhanced berberine delivery in psoriasis: targeting chemerin and MAPK pathways. J Drug Deliv Sci Technol. 2025;112:107291. https:\/\/doi.org\/10.1016\/j.jddst.2025.107291.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4727_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104595","author":"N Chauhan","year":"2022","unstructured":"Chauhan N, Vasava P, Khan SL, Siddiqui FA, Islam F, Chopra H, et al. Ethosomes: a novel drug carrier. Ann Med Surg. 2022. https:\/\/doi.org\/10.1016\/j.amsu.2022.104595.","journal-title":"Ann Med Surg"},{"issue":"1\u20132","key":"4727_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(99)00037-X","volume":"40","author":"N D\u00fczg\u00fcne\u015f","year":"1999","unstructured":"D\u00fczg\u00fcne\u015f N, Nir S. Mechanisms and kinetics of liposome\u2013cell interactions. Adv Drug Deliv Rev. 1999;40(1\u20132):3\u201318. https:\/\/doi.org\/10.1016\/S0169-409X(99)00037-X.","journal-title":"Adv Drug Deliv Rev"},{"key":"4727_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/6640103","volume":"202","author":"Preeti","year":"2023","unstructured":"Preeti, Sambhakar S, Malik R, Bhatia S, Al Harrasi A, Rani C, et al. Nanoemulsion: an emerging novel technology for improving the bioavailability of drugs. Scientifica (Cairo). 2023;202:1\u201325. https:\/\/doi.org\/10.1155\/2023\/6640103.","journal-title":"Scientifica (Cairo)."},{"issue":"1","key":"4727_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/1556-276X-9-247","volume":"9","author":"E Abbasi","year":"2014","unstructured":"Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, et al. Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett. 2014;9(1):247. https:\/\/doi.org\/10.1186\/1556-276X-9-247.","journal-title":"Nanoscale Res Lett"},{"issue":"8","key":"4727_CR48","doi-asserted-by":"publisher","first-page":"3496","DOI":"10.1021\/acs.macromol.4c00427","volume":"57","author":"R Du","year":"2024","unstructured":"Du R, Fielding LA. pH-responsive nanogels generated by polymerization-induced self-assembly of a succinate-functional monomer. Macromolecules. 2024;57(8):3496\u2013501. https:\/\/doi.org\/10.1021\/acs.macromol.4c00427.","journal-title":"Macromolecules"},{"issue":"1","key":"4727_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23303","volume":"10","author":"A Garg","year":"2024","unstructured":"Garg A, Lai W-C, Chopra H, Agrawal R, Singh T, Chaudhary R, et al. Nanosponge: a promising and intriguing strategy in medical and pharmaceutical Science. Heliyon. 2024;10(1):e23303. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23303.","journal-title":"Heliyon"},{"issue":"1","key":"4727_CR50","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1021\/acsmaterialsau.4c00125","volume":"5","author":"R Hulimane Shivaswamy","year":"2025","unstructured":"Hulimane Shivaswamy R, Binulal P, Benoy A, Lakshmiramanan K, Bhaskar N, Pandya HJ. Microneedles as a promising technology for disease monitoring and drug delivery: a review. ACS Mater Au. 2025;5(1):115\u201340. https:\/\/doi.org\/10.1021\/acsmaterialsau.4c00125.","journal-title":"ACS Mater Au"},{"issue":"2","key":"4727_CR51","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5681\/bi.2012.011","volume":"2","author":"P Kothamasu","year":"2012","unstructured":"Kothamasu P, Kanumur H, Ravur N, Maddu C, Parasuramrajam R, Thangavel S. Nanocapsules: the weapons for novel drug delivery systems. BioImpacts. 2012;2(2):71\u201381. https:\/\/doi.org\/10.5681\/bi.2012.011","journal-title":"BioImpacts."},{"issue":"2","key":"4727_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/1061186X.2025.2544783","volume":"34","author":"R Mitra","year":"2026","unstructured":"Mitra R, Sharma DK, Ghosh A, Senapati S. Recent advancements in nanoparticle-based topical drug delivery systems for psoriasis treatment. J Drug Target. 2026;34(2):151\u201368. https:\/\/doi.org\/10.1080\/1061186X.2025.2544783.","journal-title":"J Drug Target"},{"issue":"3","key":"4727_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.nexres.2025.100731","volume":"2","author":"A Gupta","year":"2025","unstructured":"Gupta A, Gupta SK. Interplay of novel formulation-based treatment strategies for psoriasis: advancing therapeutic outcomes. Next Res. 2025;2(3):100731. https:\/\/doi.org\/10.1016\/j.nexres.2025.100731.","journal-title":"Next Res"},{"issue":"12","key":"4727_CR54","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1007\/s13555-022-00840-9","volume":"12","author":"A Drakos","year":"2022","unstructured":"Drakos A, Vender R. A review of the clinical trial landscape in psoriasis: an update for clinicians. Dermatol Ther (Heidelb). 2022;12(12):2715\u201330. https:\/\/doi.org\/10.1007\/s13555-022-00840-9.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"5","key":"4727_CR55","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3109\/09546634.2013.789474","volume":"25","author":"K Tzogani","year":"2014","unstructured":"Tzogani K, Straube M, Hoppe U, Kiely P, O\u2019Dea G, Enzmann H, et al. The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: summary of the scientific assessment of the Committee for Medicinal Products for Human Use. J Dermatol Treat. 2014;25(5):371\u20134. https:\/\/doi.org\/10.3109\/09546634.2013.789474.","journal-title":"J Dermatol Treat"},{"issue":"4","key":"4727_CR56","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","volume":"76","author":"NRH Stone","year":"2016","unstructured":"Stone NRH, Bicanic T, Salim R, Hope W. Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics. Clin Exp Future Dir Drugs. 2016;76(4):485\u2013500. https:\/\/doi.org\/10.1007\/s40265-016-0538-7.","journal-title":"Clin Exp Future Dir Drugs"},{"issue":"11","key":"4727_CR57","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1111\/j.1468-3083.2010.03631.x","volume":"24","author":"B Ascher","year":"2010","unstructured":"Ascher B, Talarico S, Cassuto D, Escobar S, Hexsel D, Ja\u00e9n P, et al. International consensus recommendations on the aesthetic usage of botulinum toxin type A (Speywood Unit)\u2014part I: upper facial wrinkles. J Eur Acad Dermatol Venereol. 2010;24(11):1278. https:\/\/doi.org\/10.1111\/j.1468-3083.2010.03631.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"4727_CR58","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1080\/10717544.2022.2096718","volume":"29","author":"Y-P Zhao","year":"2022","unstructured":"Zhao Y-P, Han J-F, Zhang F-Y, Liao T-T, Na R, Yuan X-F, et al. Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy. Drug Deliv. 2022;29(1):2269\u201382. https:\/\/doi.org\/10.1080\/10717544.2022.2096718.","journal-title":"Drug Deliv"},{"issue":"1","key":"4727_CR59","doi-asserted-by":"publisher","DOI":"10.1088\/1757-899X\/774\/1\/012108","volume":"774","author":"X Liu","year":"2020","unstructured":"Liu X, Li W, Xuan G. Preparation and characterization of \u03b2-cyclodextrin nanosponges and study on enhancing the solubility of insoluble nicosulfuron. IOP Conf Ser Mater Sci Eng. 2020;774(1):012108. https:\/\/doi.org\/10.1088\/1757-899X\/774\/1\/012108.","journal-title":"IOP Conf Ser Mater Sci Eng"},{"key":"4727_CR60","doi-asserted-by":"publisher","first-page":"4763","DOI":"10.2147\/IJN.S247007","volume":"15","author":"YO Agrawal","year":"2020","unstructured":"Agrawal YO, Mahajan UB, Mahajan HS, Ojha S. Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis by moderating inflammation: formulation, optimization, characterization, in-vitro and in-vivo studies. Int J Nanomed. 2020;15:4763\u201378. https:\/\/doi.org\/10.2147\/IJN.S247007.","journal-title":"Int J Nanomed"},{"issue":"1\u20132","key":"4727_CR61","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ijpharm.2014.10.067","volume":"477","author":"MF Pinto","year":"2014","unstructured":"Pinto MF, Moura CC, Nunes C, Segundo MA, Costa Lima SA, Reis S. A new topical formulation for psoriasis: development of methotrexate-loaded nanostructured lipid carriers. Int J Pharm. 2014;477(1\u20132):519\u201326. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.10.067.","journal-title":"Int J Pharm"},{"issue":"2","key":"4727_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/gels8020129","volume":"8","author":"AS Khan","year":"2022","unstructured":"Khan AS, Shah KU, Mohaini MA, Alsalman AJ, Hawaj MAA, Alhashem YN, et al. Tacrolimus-loaded solid lipid nanoparticle gel: formulation development and in vitro assessment for topical applications. Gels. 2022;8(2):129. https:\/\/doi.org\/10.3390\/gels8020129.","journal-title":"Gels"},{"key":"4727_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118624","volume":"569","author":"V Savi\u0107","year":"2019","unstructured":"Savi\u0107 V, Ili\u0107 T, Nikoli\u0107 I, Markovi\u0107 B, \u010calija B, Ceki\u0107 N, et al. Tacrolimus-loaded lecithin-based nanostructured lipid carrier and nanoemulsion with propylene glycol monocaprylate as a liquid lipid: Formulation characterization and assessment of dermal delivery compared to referent ointment. Int J Pharm. 2019;569:118624. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118624.","journal-title":"Int J Pharm"},{"issue":"3","key":"4727_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2019.e01343","volume":"5","author":"PK Tripathi","year":"2019","unstructured":"Tripathi PK, Gorain B, Choudhury H, Srivastava A, Kesharwani P. Dendrimer entrapped microsponge gel of dithranol for effective topical treatment. Heliyon. 2019;5(3):e01343. https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01343.","journal-title":"Heliyon"},{"issue":"19","key":"4727_CR65","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.3390\/molecules27196328","volume":"27","author":"H Yu","year":"2022","unstructured":"Yu H, Liu Y, Zheng F, Chen W, Wei K. Erianin-loaded photo-responsive dendrimer mesoporous silica nanoparticles: exploration of a psoriasis treatment method. Molecules. 2022;27(19):6328. https:\/\/doi.org\/10.3390\/molecules27196328.","journal-title":"Molecules"},{"issue":"10","key":"4727_CR66","doi-asserted-by":"publisher","first-page":"2618","DOI":"10.1039\/D3TB02643D","volume":"12","author":"H Du","year":"2024","unstructured":"Du H, Yang J, Li M, Xia Y, Li Y, Zhu J, et al. Microneedle-assisted percutaneous delivery of methotrexate-loaded nanoparticles enabling sustained anti-inflammatory effects in psoriasis therapy. J Mater Chem B. 2024;12(10):2618\u201327. https:\/\/doi.org\/10.1039\/D3TB02643D.","journal-title":"J Mater Chem B"},{"issue":"8","key":"4727_CR67","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/14712598.2023.2247972","volume":"23","author":"M Calamia","year":"2023","unstructured":"Calamia M, Abraham I. The economics of biosimilars and challenges to biosimilar adoption in low- and middle-income countries. Expert Opin Biol Ther. 2023;23(8):653\u20137. https:\/\/doi.org\/10.1080\/14712598.2023.2247972.","journal-title":"Expert Opin Biol Ther"},{"key":"4727_CR68","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/IJN.S150319","volume":"13","author":"K Yu","year":"2017","unstructured":"Yu K, Wang Y, Wan T, Zhai Y, Cao S, Ruan W, et al. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. Int J Nanomed. 2017;13:129\u201342. https:\/\/doi.org\/10.2147\/IJN.S150319.","journal-title":"Int J Nanomed"},{"key":"4727_CR69","doi-asserted-by":"publisher","DOI":"10.71097\/IJSAT.v16.i2.6473","author":"SS Sammasagi","year":"2025","unstructured":"Sammasagi SS, Sutar KP, Hooli S. Scale-up and quality control challenges in the industrial manufacturing of nanoformulations: current trends and future perspectives. Int J Sci Technol. 2025. https:\/\/doi.org\/10.71097\/IJSAT.v16.i2.6473.","journal-title":"Int J Sci Technol"},{"issue":"4","key":"4727_CR70","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s11051-025-06293-3","volume":"27","author":"C de Souza Cardoso Delfino","year":"2025","unstructured":"de Souza Cardoso Delfino C, de Paula Pereira MC, dos Santos Oliveira M, de Carvalho Favareto I, Vallad\u00e3o VS, de Oliveira Mota M, et al. Scaling nanopharmaceutical production for personalized medicine: challenges and strategies. J Nanopart Res. 2025;27(4):108. https:\/\/doi.org\/10.1007\/s11051-025-06293-3.","journal-title":"J Nanopart Res"},{"issue":"3","key":"4727_CR71","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1007\/s13346-021-01024-2","volume":"12","author":"S Dordevic","year":"2022","unstructured":"Dordevic S, Gonzalez MM, Conejos-Sanchez I, Carreira B, Pozzi S, Acurcio RC, et al. Current hurdles to the translation of nanomedicines from bench to the clinic. Drug Deliv Transl Res. 2022;12(3):500\u201325. https:\/\/doi.org\/10.1007\/s13346-021-01024-2.","journal-title":"Drug Deliv Transl Res"},{"issue":"18","key":"4727_CR72","doi-asserted-by":"publisher","first-page":"14041","DOI":"10.3390\/ijms241814041","volume":"24","author":"MS Gatto","year":"2023","unstructured":"Gatto MS, Najahi-Missaoui W. Lyophilization of nanoparticles, does it really work? Overview of the current status and challenges. Int J Mol Sci. 2023;24(18):14041. https:\/\/doi.org\/10.3390\/ijms241814041.","journal-title":"Int J Mol Sci"},{"key":"4727_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2020.102041","volume":"60","author":"KS Maravajjala","year":"2020","unstructured":"Maravajjala KS, Swetha KL, Sharma S, Padhye T, Roy A. Development of a size-tunable paclitaxel micelle using a microfluidic-based system and evaluation of its in-vitro efficacy and intracellular delivery. J Drug Deliv Sci Technol. 2020;60:102041. https:\/\/doi.org\/10.1016\/j.jddst.2020.102041.","journal-title":"J Drug Deliv Sci Technol"},{"key":"4727_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.122368","volume":"629","author":"E Chiesa","year":"2022","unstructured":"Chiesa E, Bellotti M, Caimi A, Conti B, Dorati R, Conti M, et al. Development and optimization of microfluidic assisted manufacturing process to produce PLGA nanoparticles. Int J Pharm. 2022;629:122368. https:\/\/doi.org\/10.1016\/j.ijpharm.2022.122368.","journal-title":"Int J Pharm"},{"issue":"2","key":"4727_CR75","doi-asserted-by":"publisher","first-page":"225","DOI":"10.47583\/ijpsrr.2021.v69i02.033","volume":"69","author":"PS Milmile","year":"2021","unstructured":"Milmile PS, Patil RJ, Nikam SM, Wadher KJ, Umekar MJ. Quality by design: a methodical approach in development of nano delivery system. Int J Pharm Sci Rev Res. 2021;69(2):225\u20138. https:\/\/doi.org\/10.47583\/ijpsrr.2021.v69i02.033.","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"3","key":"4727_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2022042927","volume":"40","author":"S Mehrotra","year":"2023","unstructured":"Mehrotra S, Salwa A, Kumar L. Implementation of quality by design in the formulation and development of nanocarrier-based drug delivery systems. Crit Rev Ther Drug Carrier Syst. 2023;40(3):1\u201346. https:\/\/doi.org\/10.1615\/CritRevTherDrugCarrierSyst.2022042927.","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"3","key":"4727_CR77","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/pharmaceutics12030246","volume":"12","author":"P Shah","year":"2020","unstructured":"Shah P, Goodyear B, Haq A, Puri V, Michniak-Kohn B. Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform. Pharmaceutics. 2020;12(3):246. https:\/\/doi.org\/10.3390\/pharmaceutics12030246.","journal-title":"Pharmaceutics"},{"issue":"3","key":"4727_CR78","doi-asserted-by":"publisher","first-page":"333","DOI":"10.26599\/nbe.2025.9290132","volume":"17","author":"X Li","year":"2025","unstructured":"Li X, Liu S, Yuan H. Innovative nanomedicine approaches for psoriasis: advancements, challenges, and future directions. Nano Biomed Eng. 2025;17(3):333\u201345. https:\/\/doi.org\/10.26599\/nbe.2025.9290132.","journal-title":"Nano Biomed Eng"},{"issue":"4","key":"4727_CR79","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s40265-020-01261-8","volume":"80","author":"M Nogueira","year":"2020","unstructured":"Nogueira M, Puig L, Torres T. JAK inhibitors for treatment of psoriasis: focus on selective TYK2 inhibitors. Drugs. 2020;80(4):341\u201352. https:\/\/doi.org\/10.1007\/s40265-020-01261-8.","journal-title":"Drugs"},{"issue":"24","key":"4727_CR80","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1111\/bph.15673","volume":"178","author":"YH Pan","year":"2021","unstructured":"Pan YH, You YP, Sun L, et al. The STING antagonist H-151 ameliorates psoriasis via suppression of STING\/NF-\u03baB-mediated inflammation. Br J Pharmacol. 2021;178(24):4907\u201322. https:\/\/doi.org\/10.1111\/bph.15673.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"4727_CR81","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13096","volume":"94","author":"H Sigurgrimsdottir","year":"2021","unstructured":"Sigurgrimsdottir H, Bjornsdottir EO, Eysteinsdottir JH, et al. Keratinocytes secrete multiple inflammatory and immune biomarkers, which are regulated by LL-37, in a psoriasis mimicking microenvironment. Scand J Immunol. 2021;94(6):e13096. https:\/\/doi.org\/10.1111\/sji.13096.","journal-title":"Scand J Immunol"},{"key":"4727_CR82","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Chen YD, Cui L, et al. Advances in the pathogenesis of psoriasis: From keratinocyte perspective. Cell Death Dis. 2022;13:81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3.","journal-title":"Cell Death Dis"},{"key":"4727_CR83","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.onano.2023.100123","volume":"10","author":"M Alam","year":"2023","unstructured":"Alam M, Rizwanullah M, Mir SR, Amin S. Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis. OpenNano. 2023;10:100123. https:\/\/doi.org\/10.1016\/j.onano.2023.100123.","journal-title":"OpenNano"},{"issue":"17","key":"4727_CR84","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.3390\/ijms241713313","volume":"24","author":"H-J Lee","year":"2023","unstructured":"Lee H-J, Kim M. Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. 2023;24(17):13313. https:\/\/doi.org\/10.3390\/ijms241713313.","journal-title":"Int J Mol Sci"},{"key":"4727_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.impact.2024.100523","volume":"35","author":"D Hristozov","year":"2024","unstructured":"Hristozov D, Badetti E, Bigini P, Brunelli A, Dekkers S, Diomede L, et al. Next generation risk assessment approaches for advanced nanomaterials: current status and future perspectives. NanoImpact. 2024;35:100523. https:\/\/doi.org\/10.1016\/j.impact.2024.100523.","journal-title":"NanoImpact"},{"issue":"3","key":"4727_CR86","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s12325-022-02417-6","volume":"40","author":"R Perry","year":"2023","unstructured":"Perry R, Beveridge AJ, Sears AJ, Rasmussen ER. Expert consensus on real-world use and consumption patterns of a fixed-dose combination foam for psoriasis as a reactive Management (RM) and proactive management (PAM) regimen. Adv Ther. 2023;40(3):1062\u201373. https:\/\/doi.org\/10.1007\/s12325-022-02417-6.","journal-title":"Adv Ther"},{"issue":"7","key":"4727_CR87","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1111\/jdv.20553","volume":"39","author":"AW Armstrong","year":"2025","unstructured":"Armstrong AW, Lebwohl M, Warren RB, et al. Deucravacitinib in plaque psoriasis: Four-year safety and efficacy results from the Phase 3 POETYK PSO-1, PSO-2 and long-term extension trials. J Eur Acad Dermatol Venereol. 2025;39(7):1336\u201351. https:\/\/doi.org\/10.1111\/jdv.20553.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"4727_CR88","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.3390\/ijms22083968","volume":"22","author":"HR Kim","year":"2021","unstructured":"Kim HR, Kim JC, Kang SY, et al. Rapamycin alleviates 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-induced aggravated dermatitis in mice with imiquimod-induced psoriasis-like dermatitis by inducing autophagy. Int J Mol Sci. 2021;22(8):3968. https:\/\/doi.org\/10.3390\/ijms22083968.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"4727_CR89","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.nano.2014.03.017","volume":"10","author":"MA Vetten","year":"2014","unstructured":"Vetten MA, Yah CS, Singh T, Gulumian M. Challenges facing sterilization and depyrogenation of nanoparticles: Effects on structural stability and biomedical applications. Nanomedicine. 2014;10(7):1391\u20139. https:\/\/doi.org\/10.1016\/j.nano.2014.03.017.","journal-title":"Nanomedicine"},{"key":"4727_CR90","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.addr.2018.06.024","volume":"131","author":"S M\u00fchlebach","year":"2018","unstructured":"M\u00fchlebach S. Regulatory challenges of nanomedicines and their follow-on versions: a generic or similar approach? Adv Drug Deliv Rev. 2018;131:122\u201331. https:\/\/doi.org\/10.1016\/j.addr.2018.06.024.","journal-title":"Adv Drug Deliv Rev"},{"issue":"15","key":"4727_CR91","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1080\/17435889.2025.2533107","volume":"20","author":"B Mangla","year":"2025","unstructured":"Mangla B, Kumar P, Javed S, Pathan T, Ahsan W, Aggarwal G. Regulating nanomedicines: challenges, opportunities, and the path forward. Nanomedicine. 2025;20(15):1911\u201327. https:\/\/doi.org\/10.1080\/17435889.2025.2533107.","journal-title":"Nanomedicine"},{"key":"4727_CR92","doi-asserted-by":"publisher","DOI":"10.71097\/IJSAT.v16.i2.6473","author":"SS Sammasagi","year":"2025","unstructured":"Sammasagi SS, Sutar KP, Hooli S. Scale-up and quality control challenges in the industrial manufacturing of nanoformulations: current trends and future perspectives. Int J Sci Adv Technol. 2025. https:\/\/doi.org\/10.71097\/IJSAT.v16.i2.6473.","journal-title":"Int J Sci Adv Technol."},{"key":"4727_CR93","doi-asserted-by":"publisher","DOI":"10.1002\/puh2.158","author":"P Chejor","year":"2024","unstructured":"Chejor P, Dorji T, Dema N, Stafford A. Good manufacturing practice in low- and middle-income countries: challenges and solutions for compliance. Public Health Challenges. 2024. https:\/\/doi.org\/10.1002\/puh2.158.","journal-title":"Public Health Challenges"},{"key":"4727_CR94","doi-asserted-by":"publisher","DOI":"10.1155\/dth\/9464860","author":"N Yu","year":"2025","unstructured":"Yu N, Wang Y, Cui L, Li X, Gu J, Bi X, et al. Comprehensive analysis of effectiveness and cost\u2010effectiveness of treatments for psoriasis integrating clinician\u2010 and patient\u2010reported outcomes: a cohort study from SPEECH. Dermatol Ther. 2025. https:\/\/doi.org\/10.1155\/dth\/9464860.","journal-title":"Dermatol Ther"},{"issue":"4","key":"4727_CR95","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1001\/jamadermatol.2023.6236","volume":"160","author":"AC Egilman","year":"2024","unstructured":"Egilman AC, Kesselheim AS, Avorn J, Raymakers AJN, Rome BN. Use of efficiency frontiers to align prices and clinical benefits of biologic therapies for plaque psoriasis. JAMA Dermatol. 2024;160(4):409. https:\/\/doi.org\/10.1001\/jamadermatol.2023.6236.","journal-title":"JAMA Dermatol"},{"key":"4727_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ddr.70213","volume":"87","author":"V Singh","year":"2025","unstructured":"Singh V, Rehman U, Alqahtani T, et al. Interface-engineered nanocarriers for translational and patient-centric topical therapy in psoriasis. Drug Dev Res. 2025;87:1\u201331. https:\/\/doi.org\/10.1002\/ddr.70213.","journal-title":"Drug Dev Res"},{"issue":"1","key":"4727_CR97","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s11671-026-04569-8","volume":"21","author":"H Hu","year":"2026","unstructured":"Hu H, Ma Z, Zhang Z, Chen Y, Hu K, Zhang P, et al. Nanotechnology advances for psoriasis treatment and future prospects. Discover Nano. 2026;21(1):122.","journal-title":"Discover Nano"},{"issue":"3","key":"4727_CR98","doi-asserted-by":"publisher","first-page":"333","DOI":"10.26599\/NBE.2025.929013","volume":"17","author":"XZ Li","year":"2025","unstructured":"Li XZ, Liu SW, He Y. Innovative nanomedicine approaches for psoriasis: advancements, challenges, and future directions. Nano Biomedicine and Engineering. 2025;17(3):333\u2013345. https:\/\/doi.org\/10.26599\/NBE.2025.929013","journal-title":"Nano Biomedicine and Engineering"},{"key":"4727_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.onano.2023.100123","volume":"10","author":"M Alam","year":"2023","unstructured":"Alam M, Alsharif KF, Albratty M, Akhtar J. Promising prospects of lipid-based topical nanocarriers for the treatment of psoriasis. OpenNano. 2023;10:100123. https:\/\/doi.org\/10.1016\/j.onano.2023.100123.","journal-title":"OpenNano"},{"key":"4727_CR100","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.70213","author":"V Singh","year":"2026","unstructured":"Singh V, Rehman U, Alqahtani T, Shmrany HA, Gupta G, Goh KW, et al. Interface\u2010engineered nanocarriers for translational and patient\u2010centric topical therapy in psoriasis. Drug Dev Res. 2026. https:\/\/doi.org\/10.1002\/ddr.70213.","journal-title":"Drug Dev Res"},{"key":"4727_CR101","doi-asserted-by":"publisher","DOI":"10.2174\/0118715265298802240603120251","author":"A Singh","year":"2025","unstructured":"Singh A, Kumar P, Sharma H. Breakthrough opportunities of nanotheranostics in psoriasis: from pathogenesis to management strategy. Infect Disord Drug Targets. 2025. https:\/\/doi.org\/10.2174\/0118715265298802240603120251.","journal-title":"Infect Disord Drug Targets"}],"container-title":["Discover Nano"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11671-026-04727-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11671-026-04727-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T19:01:23Z","timestamp":1781377283000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s11671-026-04727-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4727"],"URL":"https:\/\/doi.org\/10.1186\/s11671-026-04727-y","relation":{},"ISSN":["2731-9229"],"issn-type":[{"value":"2731-9229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the manuscript for publication\n                      .","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"261"}}